A carregar...

Economic evaluation of chemoprevention of breast cancer with tamoxifen and raloxifene among high-risk women in Japan

Raloxifene was approved for chemoprevention against breast cancer among high-risk women in addition to tamoxifen by the US Food and Drug Administration. This study aims to evaluate cost-effectiveness of these agents under Japan's health system. A cost-effectiveness analysis with Markov model co...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kondo, M, Hoshi, S-L, Toi, M
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2009
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2634700/
https://ncbi.nlm.nih.gov/pubmed/19142182
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6604869
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!